GeoffLizzard t1_j1pq2xn wrote on December 26, 2022 at 11:54 AM Reply to E. coli bacteria can be used to create low cost COVID vaccines. A study on mice using a novel liposomal adjuvant shows the vaccine induced polyclonal antibodies in vitro, and potently neutralized homologous and heterologous SARS-CoV-2 pseudoviruses. by glawgii Oh, so the hemondungytes of the virus are poroferous with vitro-heptalization? Interesting, i never thought metaviruses in the SARS-Cov-2 strain had prolagillian amobdeni! This will be groundbreaking! Permalink −8−
GeoffLizzard t1_j1pq2xn wrote
Reply to E. coli bacteria can be used to create low cost COVID vaccines. A study on mice using a novel liposomal adjuvant shows the vaccine induced polyclonal antibodies in vitro, and potently neutralized homologous and heterologous SARS-CoV-2 pseudoviruses. by glawgii
Oh, so the hemondungytes of the virus are poroferous with vitro-heptalization? Interesting, i never thought metaviruses in the SARS-Cov-2 strain had prolagillian amobdeni! This will be groundbreaking!